EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nomadic Lactobacilli as cell factory for antibiofilm therapy

Linette Shoby Paul, Hamitha Chinganadi Hameed, Leela K V, Ashu Sharma, Jintae Lee, Moshe Shemesh, Satish Kumar Rajasekharan

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2025.1668573 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Linette Shoby Paul und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Tamil Nadu, Kattankulathur, India. Hauptthemen laut MEDLINE: Antibiosis, Biofilms, Candida albicans, Candidiasis, Vulvovaginal. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vulvovaginal candidiasis (VVC) is an infection caused by Candida albicans that presents an escalating threat to humans. Lactobacilli may play a critical role in maintaining microbiome balance in the gut and vagina as well as limiting fungal colonization, including C. albicans. Certain Lactobacilli, classified as nomadic groups is gaining immense popularity in antifungal defense due to its unique morphological adaptations. One significant adaptation is the V-shaped cell chaining observed under low pH conditions governed by the LuxS-mediated quorum-sensing system. This structural adaptation potentiates altered secondary metabolite secretion. These geometric forms are not solely survival responses but reflect a structurally coordinated strategy that enhances both antibiofilm and antihyphal activities. In this perspective, we argue that morphology-driven transitions identify nomadic Lactobacilli as a promising frontier in probiotic therapy. By shifting from conventional probiotic formulations to structured microbial interventions, we propose the development of novel sustainable therapeutics for anticandidal therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntibiosisBiofilmsCandida albicansCandidiasis, VulvovaginalLactobacillusProbioticsFemaleHumansHydrogen-Ion ConcentrationQuorum SensingVagina

Stichwörter der Autor:innen

C. albicansLactobacilliV-shaped structurecellular heterogeneitynomadicprobiotic biofilm

Autor:innen und Institutionen

  • Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Tamil Nadu, Kattankulathur, India.
  • Department of Microbiology, SRM Medical College Hospital and Research Centre (SRMMCH&RC), SRM Institute of Science and Technology, Kattankulathur, India.
  • Department of Oral Biology, School of Dental Medicine, University at Buffalo, Buffalo, NY, United States.
  • School of Chemical Engineering, Yeungnam University, Gyeongsan, Republic of Korea.
  • Department of Food Science, Institute of Postharvest Technology and Food Sciences, Agricultural Research Organization (ARO), Volcani Institute, Rishon LeZion, Israel.

Zitieren

APA

Paul, L. S., Hameed, H. C., K V, L., Sharma, A., Lee, J., Shemesh, M., & Rajasekharan, S. K. (2025). Nomadic Lactobacilli as cell factory for antibiofilm therapy. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1668573

Vancouver

Paul LS, Hameed HC, K V L, Sharma A, Lee J, Shemesh M, et al. Nomadic Lactobacilli as cell factory for antibiofilm therapy. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1668573

BibTeX
@article{Paul2025,
  author = {Paul, Linette Shoby and Hameed, Hamitha Chinganadi and K V, Leela and Sharma, Ashu and Lee, Jintae and Shemesh, Moshe and Rajasekharan, Satish Kumar},
  title = {Nomadic Lactobacilli as cell factory for antibiofilm therapy},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1668573}
}
Kostenlos starten →